申请人:Boehringer Markus
公开号:US20120122854A1
公开(公告)日:2012-05-17
The invention is concerned with novel carbocyclyl fused cyclic amines of formula (I)
wherein A, X
1
to X
3
, Y
1
to Y
3
, Z, R
1
, R
2
, m and n are as defined in the description and in the claims, as well as physiologically acceptable salts thereof. These compounds inhibit the coagulation factor Xa and can be used as medicaments.
该发明涉及公式(I)中的新型碳环融合环状胺化合物,其中A,X1至X3,Y1至Y3,Z,R1,R2,m和n的定义如说明书和权利要求中所述,以及其生理上可接受的盐。这些化合物抑制凝血因子Xa,并可用作药物。